RhoA Y42C drives cell plasticity and PD-1-mediated immune evasion of diffuse gastric cancer
Open Access
- 6 October 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Diffuse gastric cancer (DGC) is an aggressive gastric cancer subtype with a poor prognosis. The RHOA Y42C mutation is recurrent in DGC, but its independent oncogenic role is unclear. Next-Generation Sequencing of 431 DGC cases revealed that most RHOA mutations occurred without CDH1 alterations. Using genetically engineered gastric organoids, we show that RhoaY42C, along with KrasG12D and Trp53 loss (RKP), induces DGC, independently of Cdh1 loss. Single-cell and spatial transcriptomics reveal that RKP tumors exhibit mucinous histopathology and a specific lineage trajectory from Aqp5+ cells to Muc1/Muc4+ cells. RKP tumors create an immunosuppressive tumor microenvironment where AREG, transactivated by RhoA Y42C–YAP1, causes T cell exhaustion via PD-1 upregulation. Unlike E-cadherin loss-associated DGC, RKP tumors are highly susceptible to PD-1 blockade. Additionally, the RHOA Y42C mutation correlates with PD-1 upregulation in human DGC samples. These findings redefine the oncogenic role of RhoA Y42C, confirming its sufficiency for DGC development and suggesting PD-1 inhibition as a viable therapeutic option for DGC patients carrying this mutation.Keywords
Funding Information
- National Cancer Institute (CA193297)
- National Cancer Institute (CA278971)
- National Cancer Institute (CA279867)
- National Cancer Institute (CA286761)
- National Cancer Institute (CA286745)
- Cancer Prevention and Research Institute of Texas (RP180672)
- Cancer Prevention and Research Institute of Texas (RP200504)
- Cancer Prevention and Research Institute of Texas (RP240432)
This publication has 81 references indexed in Scilit:
- Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging TherapeuticsTargeted Oncology, 2024
- An oncogenic phenoscape of colonic stem cell polarizationCell, 2023
- The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesisCellular Oncology, 2023
- Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesCancer Cell, 2018
- NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic CancerCell, 2016
- Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell NicheCancer Cell, 2015
- Clinicopathological Variation of Lauren Classification in Gastric CancerPathology and Oncology Research, 2015
- RhoA Mutations Identified in Diffuse Gastric CancerCancer Cell, 2014
- Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potentialGastric Cancer, 2012